COMPANY OVERVIEW

Pulmocide Ltd is a venture capital funded company based in London with a focus on novel inhaled therapies for life threatening lung infections caused by Aspergillus (a fungal pathogen) and Respiratory Syncytial Virus (RSV).

---

LOCATION

London, , UK

---

THERAPEUTIC AREAS

Infectious Disease

Respiratory Disease

---

WEBSITE

https://www.pulmocide.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 8, 2023

Pulmocide Announces Expansion of Management Team

Dec 6, 2022

Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole

Dec 6, 2022

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing

Dec 6, 2022

Dec 6, 2022

For More Press Releases

---